Cure8 research brief
Many reproductive-aged women with IBD and other autoimmune conditions may not have documented claims for prescription or permanent contraception, including women taking medications with potential fetal risks. That gap matters for pregnancy prevention and preconception planning.
Reproductive-aged adults with IBD or other autoimmune diseases, clinicians who prescribe potentially fetotoxic therapies, family-planning counselors, and health policy researchers focused on access to contraception.
The study used 2019 IBM MarketScan commercial and multistate Medicaid claims to compare contraception claims prevalence for women with IBD, SLE, RA, and MS against women without these conditions. Overall, fewer than half of insured women with these autoimmune diseases had claims for permanent or prescription contraception.
Patterns differed by payer: commercially insured women with SLE had lower claims for any method and combined hormonal contraception but higher long-acting reversible contraception (LARC) claims; Medicaid-insured women with IBD, MS, RA, and SLE were more likely to have any method and LARC claims compared with women without selected autoimmune diseases.
Among women prescribed selected fetotoxic medications, about 70–72% had no contraception claims. Study limits and tone: This brief summarizes the article abstract and claims-based analysis; it does not represent a full review of the complete paper or underlying patient records.
Claims data capture billed services and prescriptions but may miss contraceptives obtained without insurance claims (e.g., over-the-counter methods, confidential services, or services outside the captured databases).
This is a claims-data observational analysis (2019 MarketScan commercial and multistate Medicaid). Claims indicate billed services and prescriptions but can undercount contraception obtained without an insurance claim. The curation is grounded in the article abstract.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
This helps people with IBD and their care teams make delivery plans: if perianal disease is not active, having IBD alone was not linked to higher perineal injury risk in first-time vaginal births in this study.
Pregnancy planning and contraception are important for people with IBD because active disease at conception is linked to worse pregnancy outcomes. The article shows many women with IBD are unsure about how contraception...
People with IBD and other IMIDs often need ongoing medication during pregnancy.
